Search
for
Sort by
Research 31–60 of 423
- Diseases of the Canine Prostate Gland
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- The Influence of Flightless I: Regeneration versus Wound Healing
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Dyad of infantile cutaneous and thymic Langerhans cell histiocytosis: Is it rare?
- Author response: Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes
- Decision letter: Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes
- Inflammatory and non-melanocytic tumoral pathology of the nail
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- Is knowledge about the genetic and epigenetic alterations in melanoma a basis for targeted therapy?
- Editor's evaluation: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma
- 42761 The elusive BAP1 mutation in pediatric melanocytic tumors
- Author response: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma
- Decision letter: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma
- A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia
- A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia
- Regulation of melanocyte stem cell behavior by the niche microenvironment
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Exploiting the origins of Ras mediated squamous cell carcinoma to develop novel therapeutic interventions
- Targeted therapy in melanoma
- Genetics of thyroid lesions updated
- Progress in Dermatology and Venereology in 2023 as reflected in the Journal of the European Academy of Dermatology and Venereology
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Management of Toxicities of Targeted Therapies
- LB1031 Immune Cell-Mediated Amplification of Stem Cell Activation in Hairy Melanocytic Nevus via Osteopontin-CD44 Axis
- Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities
- America - A Diversity of Life Styles.
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma